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THE cell-to-cell interactions during chronic inflamma-
tory diseases likely contribute to leukocyte accumula-
tion leading  to increased  pathology and  organ dys-
function.  In  particular,  there  is  a  paucity  of
information relating to the maintenance of chronic
fibrotic  diseases.  Using  a  lung  fibroblast  line  and
enriched monocyte populations, we have investigated
the activational events which contribute to the pro-
duction of two C-C chemokines, macrophage inflam-
matory  protein-1  alpha  (MIP-1a )  and  monocyte
chemoattractant protein-1 (MCP-1), during fibroblast-
monocyte interactions. Neither the fibroblast cell line
(16 lu)  nor  isolated  monocytes  alone  produced  sig-
nificant  levels  of  MIP-1a or  MCP-1. However,  when
isolated monocytes were layered onto 16 lu fibroblast
monolayers a significant increase in MIP-1a and MCP-
1  production  was  observed.  The  use  of  fixed  cell
populations  indicated  that  the  MIP-1a was  derived
from monocytes and MCP-1 from both cell popula-
tions. To examine the molecules which were required
for  chemokine  production  during  the  interaction,
specific  antibodies  were  used  in  the  co-cultures.
Blocking b 3-integrin interactions significantly inhib-
ited  MIP-1a production.  In  contrast,  beta-integrin
interactions had no effect on the MCP-1 production,
while,  neutralization of  TNF  significantly decreased
MCP-1 production during the co-culture. These data
indicate  that  fibroblast–monocyte  interactions
induce  chemokine  production  through  different
mechanisms and  a combination of  these responses
may  contribute  to  the  maintenance  of  the  mono-
nuclear  cell  accumulation  during  disease
progression.
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Introduction
The  accumulation  of  leukocytes  during  infectious
diseases is paramount for host protection. However,
persistent leukocyte influx during chronic inflamma-
tory  diseases  appears  to  be  a  driving  force  behind
tissue  pathology.
1,2 In  particular,  the  consistent
recruitment of monocytes to fibrotic tissue has been
identified as a hallmark of disease progression.
3,4 The
mechanisms  which  regulate  leukocyte  recruitment
are  quite  complex  and  are  initiated  by  adhesion
molecules  on  the  endothelial  surface.
5,6 Once
adhered to the endothelial surface the cells can then
migrate  into  the  inflamed  tissue  following  chem-
otactic gradients. The chemokines appear to mediate
the selective recruitment of cell populations during
inflammatory  diseases.
7,8 Chemokines  are  divided
into two distinct families by sequence similarity and
by  function. The  C-x-C  family  (IL-8  family  or  alpha
chemokines)  are  primarily  chemotactic  for  neu-
trophils, whereas the C-C chemokine family (MCP-1
family or beta chemokines) are primarily chemotactic
for  monocytes  and  lymphocytes.  However,  these
broad divisions are now breaking down and it appears
that both classes of chemokines are important media-
tors in both acute and chronic inflammation. One of
the more potent C-C family chemokines, macrophage
inflammatory protein-1 alpha (MIP-1a ), is made pri-
marily by leukocyte populations and not by stromal or
structural cells. In contrast, a second member of the
family, monocyte chemoattractant protein-1 (MCP-1),
can  be  made  by  both  immune  and  non-immune
cells.
Once  the  cells  have  moved  into  the  tissue,  they
continue  to  interact  by  cell-to-cell  contact  with
structural cells within the tissue or organ. In earlier
studies,  it  has  been  demonstrated  that  monocyte/
macrophage interaction with various cell populations
(endothelial cells, synovial fibroblasts) can drive the
production  of  chemokines  and  may  possibly  be  a
mechanism for maintaining the persistent leukocyte
influx  observed  during  chronic  diseases.
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to be regulated by adhesive interactions between the
leukocyte  and  the  tissue  cells. These  mechanisms,
although intuitive, may be differential depending on
the  state  of  the  inflammatory  response,  the  cells
involved, the  chemokines produced,  and  the tissue
location of the response.
In the present studies, the results demonstrate that
two C-C family chemokines, MIP-1a and MCP-1, are
produced  during  monocyte–fibroblast  interactions.
The  two  chemokines,  however,  are  differentially
regulated  during  this  response:  MIP-1a is  made  by
only the monocytes and dependent upon b 3-integrin
ligation, whereas MCP-1 is made by both cell popula-
tions and  the mechanism was not dependent  upon
beta-integrins,
1–3 but rather on cytokine (TNF) activa-
tion. These studies demonstrate novel mechanisms of
regulation of C-C chemokine production.
Materials and Methods
Mononuclear cell isolation
Peripheral  blood  was  drawn  into  a  heparinized
syringe from healthy volunteers, diluted 1:1 in normal
saline,  and  mononuclear  cells  separated  by  density
gradient  centrifugation.  The  recovered  cells  were
washed three times with RPMI 1640. The PBMs were
then layered onto a density gradient (1.068 g/ml) for
the  enrichment  of  monocytes  (Atlanta  Biologicals,
Atlanta,  GA). The  isolated  cells  were  then  washed,
cytospun  onto  a  glass  slide,  stained  with  Diff-Quik
(Baxter,  McGaw,  IL)  and  differentially  counted. The
purity  of  the  monocytes  from  the  gradient  were
consistently between 75 and 80% monocytes with the
remainder lymphocytes.
16lu fibroblast cultures
The  transformed  fibroblast  cell  line,  16 lu,  was
obtained  from  ATCC  (CCL  204)  and  cultured  as
required in Eagle’s minimum essential medium with
non-essential  amino acids and  Earle’s BSS with 10%
fetal  calf  serum.  The  cells  were  grown  to  near
confluent monolayers in six-well tissue culture plates
and fresh media applied prior to utilizing them in the
assays.
Fibroblast:monocyte cocultures
Enriched  monocyte  populations  (5  3 10
5 cells/ml)
were layered onto unstimulated 16 lu fibroblast mono-
layers in six-well plates. The monocyte enriched cells
were  added  to  the  fibroblasts  in  a  total  of  1 ml  of
media  in  the  60 mm  culture  dishes.  Culture  super-
natants were collected at 1 to 24 h after co-culture.
Peak MCP-1 and MIP-1a production was detected at
24 h of co-culture.
Blocking cellular interactions
To  demonstrate  that  cell-to-cell  interactions  were
required for production of the chemokines, fixed cell
populations  were  used  (4%  paraformaldehyde  for
5 min).  Subsequently,  blocking  antibodies  to  beta-
integrins (Chemicon, Temecula, CA) and/or adhesion
molecules  (R&D  Systems,  MN)  were  used  to  block
adhesion of the two cell populations. The antibodies
were used at a concentration of 5 m g/ml. In addition,
blocking polyclonal antibodies to IL-1 and TNF were
also used at  a 1:200  dilution  in  culture to examine
inflammatory cytokine networks.
MIP-1a and MCP-1 ELISA
Extracellular immunoreactive MIP-1a and MCP-1 was
quantitated  using  a  modification  of  a  double-ligand
method as previously described.
12 Standards were 1/2
log dilutions of recombinant MIP-1a and MCP-1 from
1 pg/ml to 100 ng/ml. This ELISA method consistently
detected concentrations above 10 pg/ml and did not
crossreact with MIP-1b , RANTES, IL-1a /b , TNFa , ENA-
78, IL-8, or NAP-2.
Statistical analysis
Data  are  expressed  as  means  ±  SEM.  Data  that
appeared  statistically  significant  were  compared  by
ANOVA for comparing the means of multiple groups,
and considered significant if P values were less than
0.05.
Results
Fibroblast: monocyte coculture induces C-C
family chemokines in an adherence-dependent
mechanism
To  determine  whether  monocyte  interactions  with
fibroblast  induced  an  activational  event,  enriched
monocytes were layered onto 16 lu fibroblast mono-
layers  and  cultured  for  24 h  at  37°C.  The  data
demonstrates that neither monocytes nor fibroblasts
by themselves produced substantial levels of MIP-1a
(Fig. 1) or MCP-1 (Fig. 2). However, when the two cell
populations  were  cultured  together  a  synergistic
increase in both chemokines was observed. In con-
trast, enriched lymphocyte populations (~80%) dem-
onstrated little increase in the two chemokines when
added to the fibroblasts (data not shown). To deter-
mine which cell populations were responsible for the
chemokine  production,  one of the cell populations
was  fixed  with  4%  paraformaldehyde  prior  to  the
coculture  procedure.  MIP-1a production  was
observed only when  the fibroblasts were fixed and
monocytes were not, indicating that only the mono-
cytes  were  responsible  for  the  MIP-1a production
(Fig.  1),  following  previous  studies.  In  contrast,
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increased MCP-1 production was also observed only
when fibroblast population was fixed, indicating that
viable  monocytes  needed  to  be  present  to  incude
MCP-1  production  during the cell-to-cell interaction
(Fig. 2). These studies established that an activational
event  occurred  following  interaction  between  the
two cell populations.
Differential regulation of C-C chemokines
during monocyte-fibroblast interactions
To determine the mechanism of chemokine produc-
tion during cell-to-cell interaction, antibodies specific
for inflammatory cytokines and  adhesion  molecules
were  utilized.  It  has  previously  been  demonstrated
that TNF and IL-1 are strong inducers of chemokine
production in multiple cell types. It was interesting
that even  though fibroblasts are known  to produce
MCP-1  and  likely  the  main  source  of  MCP-1,  no
increase  was  observed  when  the  fixed  monocytes
were layered onto them. When antibodies to TNF and
IL-1  were  added  into  the  coculture  no  decrease  in
MIP-1a was observed (Fig. 3). In contrast, when MCP-
1 production was examined, treatment of the cocul-
tures with  anti-TNF significantly  decreased  the pro-
duction  of  MCP-1,  whereas  anti-IL-1  only  slightly
inhibited  (Fig.  4).  These  latter  studies  indicate  a
differential  regulation  of  these  two  C-C  family
chemokines.
C-C chemokines in fibroblast–monocyte interaction
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FIG. 1. MIP-1a production during fibroblast–monocyte inter-
action. Enriched monocyte populations  were layered onto
fibroblast monolayers. Either the monocytes or the fibroblast
were fixed with 4% paraformaldehyde (5min) and MIP-1a
levels were determined in 2h culture supernatants. MIP-1a
was  generated  by  monocytes  but  not  fibroblasts.  Data
represents  Mean  ±  SE  from  two  different  experiments.
*P<0.05.
FIG. 2. MCP-1 production during fibroblast–monocyte inter-
action. Enriched monocyte populations  were layered onto
fibroblast monolayers. Either the monocytes or the fibroblast
were fixed with 4% paraformaldehyde  (5min) and MCP-1
levels were determined in 2h culture supernatants. MCP-1
was  produced  by  both  cell  populations.  Data  represents
mean ± SE from two different experiments. P<0.05
FIG. 3. MIP-1a production is not affected by antibodies to
either  IL-1  or  TNF.  Antibodies  were  added  to  fibroblast–
monocyte co-culture at time 0 at a concentration of 5m g/ml.
After  24h  of  co-culture  the  culture  supernatant  was  har-
vested and MIP-1a was measured using a specific ELISA.
Data represents mean ± SE of two repeat experiments. No
significant decrease in MIP-1a was observed. *P<0.05
FIG. 4. MCP-1 production was decreased by antibodies to
TNF and IL-1. Antibodies were added to fibroblast–monocyte
co-culture at time 0 at a concentration of 5m g/ml. After 24h
of  co-culture  the  culture  supernatant  was  harvested  and
MCP-1 was measured using a specific ELISA. Data repre-
sents mean  ± SE  of two repeat experiments. Statistically
significant  decreases  in  MCP-1  was  observed  in  cultures
treated with anti-TNF. *P<0.05M
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Next, since the chemokine production was differ-
entially inhibited by fixation of one or the other cell
populations or by separation by transwells, the role of
adhesion  molecules  was  examined.  Blocking  anti-
bodies  to  beta-integrins  (b 1,2,3)  or  adhesion  mole-
cules (ICAM-1, VCAM-1) were added to the two cell
populations (5 m g/ml) for 15 min prior to combining
them.  The  data  indicated  that  only  antibodies  to
b 3-integrins significantly inhibited MIP-1a , while anti-
bodies  to  other  b -integrins  (b 1,  b 2)  or  adhesion
molecules (ICAM-1, VCAM-1) had no significant affect
on MIP-1a production (Fig. 5). In contrast, none of
the antibodies to beta-integrins or adhesion molecules
(ICAM-1,  VCAM-1)  inhibited  MCP-1  (Fig.  6).  Inter-
estingly,  antibodies  to  b 1-integrins  appeared  to
increase the production of MCP-1. Altogether, these
data  suggest  that  even  though  the  two  C-C  family
chemokines are produced during the adhesion event
they are differentially regulated. MIP-1a appears to be
dependent  upon  adhesion-mediated  pathways,
whereas MCP-1 appears to require cytokine signaling
pathways for its production. Thus, even though these
two C-C chemokines have overlapping functions in
vitro, they appear to be differentially induced during
the cell-to-cell interactions.
Discussion
The persistent production of chemokines during an
inflammatory response is likely required to maintain
the constant influx of leukocytes which accompanies
the development of chronic disease.
13–15 The mecha-
nism which was examined in this study was whether
the  cell-to-cell  interaction  of  monocytes  with  fibro-
blasts  was  sufficient  to  drive  the  production  of
chemokines.  The  production  of  C-C  family  chem-
okines,  MIP-1a and  MCP-1,  may  be  one  of  the
mechanisms which maintain  chronic and/or fibrotic
lesions. Previous  studies  in  fibrotic  human  diseases
have indicated that leukocyte accumulation at the site
of fibrotic episodes is necessary to initiate, maintain,
and  progress the pathological manifestations within
the affected tissue or organ. The production  of the
chemokines in the present study was dependent on
the  interaction  of  the  two  cell  populations,  as
individual cell populations produced  relatively little
or  no  chemokine.  We  have  also  identified  that
chemokine  production  was  differentially  regulated.
MCP-1  appeared  to  be  partially  dependent  upon
monocyte-derived inflammatory cytokine production,
TNF, and not on cell adhesion molecules. In contrast,
MIP-1a was  induced  by  cell-to-cell  interactions
dependent upon b 3-integrin ligation. Since b 3-integ-
rins  have  been  shown  to  bind  to  matrix  protein
components,  this  interaction  would  be  very  appro-
priate within  fibrotic lesions to maintain  the chem-
okine (MIP-1a ) production. These data begin to define
differences  in  cellular  interaction  pathways  which
may allow maintenance and  progression  of chronic
diseases. Previous studies have demonstrated chem-
okine  production  during  cell-to-cell  interactions,
9,10
but  the  differential  regulation  of  the  chemokines
within  these  studies  is  striking. This  difference  of
regulation may lie on the source of the chemokines.
MIP-1a appeared  to  be  derived  primarily  from  the
monocyte population, whereas MCP-1 can be elicited
from both the fibroblast and monocyte populations.
Altogether, these results may indicate why it may be
so difficult to modulate disease phenotypes in chronic
ailments even in the absence of any apparent inciting
agent.
C. Zickus et al.
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FIG. 5. Adhesion pathways mediated production of MIP-1a
during  fibroblast–monocyte  interaction.  Monoclonal  anti-
bodies  to  specific  adhesion  molecules  or  integrins  were
added  to  fibroblast–monocyte  co-culture  at  time  0  at  a
concentration of 5m g/ml. After 24h of co-culture the culture
supernatant was harvested and MIP-1a was measured using
a specific ELISA. Data represents mean ± SE of three repeat
experiments. Significant decreases in MIP-1a were observed
only in cultures treated with anti-b 3-integrin. *P<0.05.
FIG. 6. Blockade of adhesion pathways do not alter produc-
tion of MCP-1 production during fibroblast–monocyte inter-
action.  Monoclonal  antibodies  to  specific adhesion  mole-
cules  or  integrins  were  added  to  fibroblast–monocyte
co-culture at time 0 at a concentration of 5m g/ml. After 24h
of  co-culture  the  culture  supernatant  was  harvested  and
MCP-1 was measured using a specific ELISA. Data repre-
sents mean ± SE of three repeat experiments. *P<0.05.The induction of MIP-1a production by cell adhe-
sion  events  has  been  previously  reported  by  our
laboratories. However, it appears that the mechanism
is different depending upon the cell-type which the
monocyte binds. In a previous study endothelial cells
were  used  and  the  mechanism  was  a  b 2-integrin/
ICAM-1-mediated mechanism.
9 In the present study,
fibroblasts were utilized and it appeared that b 3-integ-
rins played a  more important  role during the inter-
action  for  MIP-1a production. The  reason  for  this
difference may lie in not only the cell type, but where
the cells are normally located. Endothelial cells which
mediated MIP-1a production via ICAM-1 interactions
are the initial  cell  type that  the monocyte contacts
during  inflammatory  events  prior  to  migration  into
the inflamed tissue. This initial activational event may
set up the induction of chemokines by monocytes for
production  at  sites  of  inflammation.  Once  at  the
inflamed area, stromal cells, such as fibroblasts, could
then  maintain  the activated  state  of  the monocyte/
macrophage for continued chemokine production via
cell-to-cell interaction. This latter mechanism appears
to  be  induced  by  b 3-integrin-mediated  events. The
ligand(s) for this integrin is primarily matrix proteins,
a  product  that  fibroblasts  are  well  suited  to
produce.
16,17
The induction of MCP-1 production by TNF and IL-1
has  been  demonstrated  by  many  laboratories  from
multiple cell types.
18–24 Interestingly, TNF appears to
be a major factor for inducing and maintaining fibrotic
responses, even in the absence of an apparent inciting
agent.
25,26 In chronic fibrotic diseases, such as idio-
pathic fibrosis (IPF) or liver cirrhosis, the persistent
production of TNF and recruitment of mononuclear
cells is maintained.
27– 29 In addition, MCP-1 appears to
play a role in chronic fibrotic events in animal models
of fibrosis.
30 Interestingly, MCP-1 was first identified
as  a  competence  factor  during  fibroblast  activation
and has been shown to participate in collagen gene
activation which can contribute to the overall pathol-
ogy  within  fibrotic  lesions.
30,31 Interestingly,  when
monocytes  were  fixed  prior  to  the  addition  to
fibroblast, no MCP-1 was induced, thus depicting the
need for  monocyte-derived  factors (TNF) to  induce
MCP-1 production. In contrast, MIP-1a was induced
via  direct  monocyte  adherence  to  fixed  fibroblasts.
The increased production  of MCP-1  via  the cellular
adhesion  following TNF  activation  may  represent  a
key  mechanism  in  progression  of  chronic  fibrotic
diseases.
The  data  in  the  present  study  suggest  that  the
interaction  of  fibroblasts  with  monocytes  initiates
chemokine  production. The  initiation  of  C-C  family
chemokines  during  this  adhesion  event  appears  to
utilize  different  mechanisms  of  activation.  Yet,  the
overall result is increased MIP-1a and MCP-1 produc-
tion  which  may  be  utilized  to  maintain  persistent
leukocyte accumulation and cellular activation with-
out  other  initiating  cytokines  or  foreign  pathogens.
These  mechanisms  may  help  to  contribute  to  the
maintenance of chronic fibrotic diseases, resulting in
significant pathogenic changes.
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